56
Participants
Start Date
December 20, 2016
Primary Completion Date
January 31, 2017
Study Completion Date
February 8, 2017
Ibuprofen
Fixed dose combination
Pseudoephedrine-HCl
Fixed dose combination
Bloemfontein Early Phase Clinical Unit, PAREXEL International (South Africa), Bloemfontein
Lead Sponsor
Boehringer Ingelheim
INDUSTRY